126 Desport JC, Mabrouk T, Bouillet P, et al. Complications and survival following radiologically and endoscopically-guided gastrostomy in patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2005; 6 (2): 88-93. 127 Shaw AS, Ampong MA, Rio A, et al. Survival of patients with ALS following institution of enteral feeding is related to pre-procedure oximetry: a retrospective review of 98 patients in a single centre. Amyotroph Lateral Scler Other Motor Neuron Disord 2006; 7 (1): 16-21. 128 Gregory S, Siderowf A, Golaszewski AL, et al. Gastrostomy insertion in ALS patients with low vital capacity: respiratory support and survival. Neurology 2002; 58: 485-7. 129 Boitano JL, Jordan T, Benditt JO. Noninvasive ventilation allows gastrostomy tube placement in patients with advanced ALS. Neurology 2001; 56: 413-4. 130 Caroscio JT, Cohen JA, Gudesblatt M. Amytriptiline in amyotrophic lateral sclerosis. N Engl J Med 1985; 313: 1.478-9. 131 Forshew DA, Bromberg M. A survey of clinicians’ practice in the symptomatic treatment of ALS. Amyotroph Lateral Scler Other Motor Neuron Disord 2003; 4(4): 2 58-263. 132 Giess R, Naumann M, Werner E, et al. Injections of botulinum toxin A into the salivary glands improve sialorrhea in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 2000; 69 (1): 121-3. 133 Manrique D. Application of botulinum toxin to reduce the saliva in patients with amyotrophic lateral sclerosis. Rev Bras Otorrinolaringol (Engl Ed) 2005; 71: 566-9. 134 Verma A, Steele J. Botulinum toxin improves sialorrhea and quality of living in bulbar amyotrophic lateral sclerosis. Muscle Nerve 2006; 34(2): 235-7. 135 Newall AR, Orser R, Hunt M. The control of oral secretions in bulbar ALS/MND. J Neurol Sci 1996; (139 Suppl): 43-4. 136 Tan EK, Lo YL, Seah A, Anchus AP. Recurrent jaw dislocation after botulinum toxin treatment for sialorrhea in amyotrophic lateral sclerosis. J Neurol Sci 2001; 190 (1-2): 95-7. 137 Winterholler MG, Erbguth FJ, Wolf S, Kat S. Botulinum toxin for the treatment of sialorrhoea in ALS: serious side effects of a transductal approach. J Neurol Neurosurg Psychiatry 2001; 70 (3): 417-8. 138 Andersen PM, Gronberg H, Franzen L, Frenegard U. External radiation of the parotid glands significatelly reduces drooling in patients with motor neuron disease with bulbar paresis. J Neurol Sci 2001; 191 (1-2): 111-4. 139 Harriman M, Morrison M, Hay J, Revonta M, Eiser A, Lentle B. Use of radiotherapy for control of sialorrhea in patients with amyotrophic lateral sclerosis. J Otolaryngol 2001; 30 (4): 242-5. 140 Newrick PG, Langton-Hewer R. Pain in motor neuron disease. J Neurol Neurosurg Psychiatry 1985; 48: 838-40. 141 Czaplinski A, Schweikert K, Strobel W, et al. Symptomatic management in amyotrophic lateral sclerosis (ALS). Schweiz Rundsch Med Prax 2006; 95: 263-71. 142 Pautex S, Janssens JP, Vuagnat H, et al. Management of patients with amyotrophic lateral sclerosis. Swiss Med Wkly 2005; 135: 626-9. 143 Chaverri Rada D, Mora Pardina JS, Mascías Cadavid J. Tratamiento integral del paciente con ELA. En: Mora Pardina JS (Ed). Esclerosis Lateral Amiotrófica. Una enfermedad tratable. Prous Science 1999; 355-68.
144
SANIDAD